These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20939998)

  • 1. Interactions of cytochrome P450s with their ligands.
    Conner KP; Woods CM; Atkins WM
    Arch Biochem Biophys; 2011 Mar; 507(1):56-65. PubMed ID: 20939998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,2,3-Triazole-heme interactions in cytochrome P450: functionally competent triazole-water-heme complexes.
    Conner KP; Vennam P; Woods CM; Krzyaniak MD; Bowman MK; Atkins WM
    Biochemistry; 2012 Aug; 51(32):6441-57. PubMed ID: 22809252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural aspects of ligand binding to and electron transfer in bacterial and fungal P450s.
    Pylypenko O; Schlichting I
    Annu Rev Biochem; 2004; 73():991-1018. PubMed ID: 15189165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change.
    Li YC; Chiang CW; Yeh HC; Hsu PY; Whitby FG; Wang LH; Chan NL
    J Biol Chem; 2008 Feb; 283(5):2917-26. PubMed ID: 18032380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria.
    Roberts AG; Campbell AP; Atkins WM
    Biochemistry; 2005 Feb; 44(4):1353-66. PubMed ID: 15667229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450s: creating novel ligand sets.
    Seward HE; Girvan HM; Munro AW
    Dalton Trans; 2005 Nov; (21):3419-26. PubMed ID: 16234920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
    Guengerich FP; Wilkey CJ; Phan TTN
    J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservation analysis of class-specific positions in cytochrome P450 monooxygenases: functional and structural relevance.
    Gricman Ł; Vogel C; Pleiss J
    Proteins; 2014 Mar; 82(3):491-504. PubMed ID: 24105833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamics of water mediating protein-ligand interactions in cytochrome P450cam: a molecular dynamics study.
    Helms V; Wade RC
    Biophys J; 1995 Sep; 69(3):810-24. PubMed ID: 8519982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYPSI: a structure-based interface for cytochrome P450s and ligands in Arabidopsis thaliana.
    Zhang G; Zhang Y; Su Z
    BMC Bioinformatics; 2012 Dec; 13():332. PubMed ID: 23256889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical study of the ligand-CYP2B4 complexes: effect of structure on binding free energies and heme spin state.
    Harris DL; Park JY; Gruenke L; Waskell L
    Proteins; 2004 Jun; 55(4):895-914. PubMed ID: 15146488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
    Locuson CW; Hutzler JM; Tracy TS
    Drug Metab Dispos; 2007 Apr; 35(4):614-22. PubMed ID: 17251307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the 1.85 A structure of CYP154A1 from Streptomyces coelicolor A3(2) with the closely related CYP154C1 and CYPs from antibiotic biosynthetic pathways.
    Podust LM; Bach H; Kim Y; Lamb DC; Arase M; Sherman DH; Kelly SL; Waterman MR
    Protein Sci; 2004 Jan; 13(1):255-68. PubMed ID: 14691240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.
    Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D
    J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.
    Sridhar J; Liu J; Foroozesh M; Stevens CL
    Molecules; 2012 Aug; 17(8):9283-305. PubMed ID: 22864238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of MM force fields around heme-Fe in the CYP-ligand complex and ab initio FMO calculations for the complex.
    Nagura Y; Sabishiro H; Chimura N; Yuguchi M; Tada N; Takimoto D; Kurita N
    J Mol Graph Model; 2024 Dec; 133():108875. PubMed ID: 39362061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.
    Williams PA; Cosme J; Vinkovic DM; Ward A; Angove HC; Day PJ; Vonrhein C; Tickle IJ; Jhoti H
    Science; 2004 Jul; 305(5684):683-6. PubMed ID: 15256616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Allosterism" in the elementary steps of the cytochrome P450 reaction cycle.
    Yoon MY; Campbell AP; Atkins WM
    Drug Metab Rev; 2004 May; 36(2):219-30. PubMed ID: 15237852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.